2025 Fee Schedule Notice
This is a contractual notice that PEHP will be updating the reimbursement fee schedule effective July 1, 2025.
The updated fee schedule reflects the CMS 2025 Relative Value Units (RVUs). To see how this may impact your reimbursement, use the Fee Schedule Lookup tool in your PEHP Provider Portal at www.pehp.org. You can compare past and current fees and download them to Excel. The 2025 fee schedule will be available for your review online no later than July 15, 2025.
A Note About Contracts: To streamline our contracting process, we are transitioning all of our individual Provider Agreements to Group Provider Agreements as of July 1, 2025. If you already have a Group Provider Agreement, you do not need to do anything. This would allow additional providers in a group/office to be added to the same Tax Identification Number without recontracting.
Reminder! On July 1, a large part of our membership will be moved to our new claims payment system. The rest of our membership will be moved on September 1, 2025. For claims to process correctly, you must submit claims with the correct ID number and portal. Learn more.
We appreciate your cooperation and patience as we implement this important system upgrade.
Questions? Contact us via the secure Message Center in the New Provider Portal at www.pehp.org.
National Drug Code Billing Requirement
Affected Providers
- Hospitals
- Other providers billing for services under the Inpatient Prospective Payment System (IPPS) and/or Outpatient Prospective Payment System (OPPS).
- Professional claims with physician-administered drugs.
Action Needed
- Make sure your reimbursement staff knows about the NDC billing requirement and any documentation requirements starting January 1, 2023.
- Claim lines will begin to deny effective date of service on or after January 1, 2023, if the HCPCS code is not present when an NDC is not billed.
Background
- PEHP requires the use of NDCs and related information when drugs are billed for professional, ancillary and facility electronic (ANSI 837P). PEHP requires inclusion of the NDC along with applicable Healthcare Common Procedure Coding System (HCPCS) or Current Procedure Terminology (CPT) code(s) on claim submissions for unlisted or “Not otherwise Classified” (NOC) or “Not Otherwise Specified” (NOS) physician administered and physician supplied drugs.
- “NDC” stands for National Drug Code. It is a unique, 3-segment numeric identifier assigned to each medication listed under Section 510 of the U.S. Federal Food, Drug and Cosmetic Act. The first segment of the NDC identifies the labeler (i.e., the company that manufactures or distributes the drug). The second segment of the NDC identifies the product (i.e., specific strength, dosage form, and formulation of a drug). The third segment identifies the package size and type. For billing purposes, the Centers of Medicare and Medicaid Services (CMS) created an 11-digit NDC derivative, which necessitates padding of the labeler (5 positions), product (4 positions) or package (2 positions) segment of the NDC with a leading zero, thus resulting in a fixed-length, 5-4-2 configuration.
- NDC is usually found on the drug label or outer packaging. The number on the packaging may be less than 11 digits. The label also displays information about the NDC unit of measurement drug.
- If the medication comes in a box with multiple vials, use the NDC number on the box (outer packaging).
Units of measure NDC descriptions:
|
UN (Unit) – Powder for injection (needs to be reconstituted), pellet, kit, patch, tablet, device
|
ML (Milliliter) – Liquid, solution, or suspension
|
GR (Gram) – Ointments, creams, inhalers, or bulk powder in jar
|
F2 (International Unit) – Products described as IU/vial or micrograms
|